Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism

Journal of Lipid Research

Volumn 47, Issue 12, 2006, Pages 2631-2639

  Dugué Pujol, Sonia ^a   Rousset, Xavier ^a   Pastier, Danièle ^a   Nhuan, Tran Quang ^a   Pautre, Virginie ^a   Chambaz, Jean ^a   Chabert, Michèle ^a   Kalopissis, Athina Despina ^a  

^a NONE

Author keywords

Apolipoprotein A II knockout mice; Chylomicrons; Plasma residence time; Postprandial hypertriglyceridemia; Transgenic mice; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A2; CARBON 14; CHYLOMICRON; LIPOPROTEIN; SUNFLOWER OIL; TRIACYLGLYCEROL; TRIOLEIN; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CATABOLISM; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RADIOACTIVITY;

ANIMALS; APOLIPOPROTEIN A-II; CHYLOMICRONS; FEMALE; HUMANS; HYPERGLYCEMIA; INTESTINES; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECOMBINANT PROTEINS; TRIGLYCERIDES;

EID: 33845562454     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600112-JLR200     Document Type: Article

References (26)

1. Miller, G. J., and N. E. Miller. 1975. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1: 16-19.
2. Capell, W. H., C. A. DeSouza, P. Poirier, M. L. Bell, B. L. Stauffer, K. M. Weil, T. L. Hernandez, and R. H. Eckel. 2003. Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 23: 307-313.
3. Haffner, S. M. 2006. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97 (Suppl.): 3A-11A.
4. Grundy, S. M., J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith, Jr., et al. 2006. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 21: 1-6.
5. Boisfer, E., G. Lambert, V. Atger, N. Q. Tran, D. Pastier, C. Benetollo, J-F. Trottier, I. Beaucamps, M. Antonucci, M. Laplaud, et al. 1999. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J. Biol. Chem. 274: 11564-11572.
6. Sauvaget, D., V. Chauffeton, S. Dugué-Pujol, A. D. Kalopissis, I. Guillet-Deniau, F. Foufelle, J. Chambaz, A. Leturque, P. Cardot, and A. Ribeiro. 2004. In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. Diabetes. 53: 672-678.
7. Pastier, D., S. Dugué, E. Boisfer, V. Atger, N. Q. Tran, A. van Tol, M. J. Chapman, J. Chambaz, P. M. Laplaud, and A. D. Kalopissis. 2001. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II. Biochemistry. 40: 12243-12253.
8. Alaupovic, P., C. Knight-Gibson, C-S. Wang, D. Downs, E. Koren, H. B. Brewer, Jr., and R. E. Gregg. 1991. Isolation and characterization of an apoA-II-containing lipoprotein (LP-AII:B complex) from plasma VLDL of patients with Tangier disease and type V hyperlipoproteinemia. J. Lipid Res. 32: 9-19.
9. Kalopissis, A. D., S. Griglio, and X. Le Liepvre. 1982. Intestinal very low density lipoprotein secretion in rats fed various amounts of fat. Biochim. Biophys. Acta. 711: 33-39.
10. Otway, S., and D. S. Robinson. 1967. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J. Physiol. 190: 321-332.
11. Schotz, M. C., A. Scanu, and I. H. Page. 1956. Effect of Triton on lipoprotein lipase of rat plasma. Am. J. Physiol. 188: 399-402.
12. Weng, W., and J. L. Breslow. 1996. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. USA. 93: 14788-14794.
13. Marzal-Casacuberta, A., F. Blanco-Vaca, B. Y. Ishida, J. Julve-Gil, J. Shen, S. Calvet-Marquez, F. Gonzalez-Sastre, and L. Chan. 1996. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J. Biol. Chem. 271: 6720-6728.
14. Folch, J., M. Lees, and G. H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
15. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
16. Scanu, A. M., and C. Edelstein. 1971. Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins. Anal. Biochem. 44: 576-588.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
18. Kalopissis, A. D., S. Griglio, M. I. Malewiak, R. Rozen, and X. Le Liepvre. 1981. Very low density lipoprotein secretion by isolated hepatocytes of fat-fed rats. Biochem. J. 198: 373-377.
19. Heath, R. B., F. Karpe, R. W. Milne, G. C. Burdge, S. A. Wootton, and K. N. Frayn. 2003. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J. Lipid Res. 44: 2065-2072.
20. Hedrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682.
21. Hime, N. J., K. J. Drew, K. Wee, P. J. Barter, and K-A. Rye. 2006. Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. J. Lipid Res. 47: 115-122.
22. Ribas, V., X. Palomer, N. Roglans, N. Rotllan, C. Fievet, A. Tailleux, J. Julve, J. C. Laguna, F. Blanco-Vaca, and J. C. Escolà-Gil. 2005. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate. Biochim. Biophys. Acta. 1737: 130-137.
23. Van't Hooft, F. M., G. Ruotolo, S. Boquist, U. de Faire, G. Eggertsen, and A. Hamsten. 2001. Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 104: 1223-1228.
24. Allayee, H., L. W. Castellani, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis. 2003. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia. Circ. Res. 92: 1262-1267.
25. Strauss, J. G., S. Frank, D. Kratky, G. Hämmerle, A. Hrzenjak, G. Knipping, A. von Eckardstein, G. M. Kostner, and R. Zechner. 2001. Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. J. Biol. Chem. 276: 36083-36090.
26. Gaenzer, H., W. Sturm, G. Neumayr, R. Kirchmair, C. F. Ebenbichler, A. Ritsch, B. Föger, G. Weiss, and J. R. Patsch. 2001. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc. Res. 52: 509-516.